Physician profile
Breann E Neiger
NPI 1184902330
$12,755.18
in general payments reported to CMS, 2019-2025
14 companies · $52.63 in 2025
The $52.63 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $37.69 · 2021: $26.28 · 2022: $52.76 · 2023: $59.41 · 2024: $91.72 · 2025: $52.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,357.35 | 2019-2025 | |
| Organogenesis INC. | $98.95 | 2019-2024 | |
| Davol INC. | $87.16 | 2019-2023 | Phasix Mesh |
| Smith+Nephew, INC. | $35.40 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $28.83 | 2024-2025 | Airsupra |
| Integra Lifesciences Corporation | $23.37 | 2020 | |
| Kerecis Limited | $19.50 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Hydrofera LLC | $19.47 | 2024 | Hydrofera Blue Ready - Border |
| Phadia US INC. | $17.36 | 2022 | |
| Kci USA, INC. | $15.46 | 2023 | 3m Coban, Promogran Prisma, V.A.C. Dermatac |
| Exact Sciences Corporation | $14.87 | 2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $14.32 | 2021 | |
| Novo Nordisk INC | $11.96 | 2021 | |
| Grifols USA, LLC | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breann Neiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.